Apollo Hospitals Surgeons Visit New York to Learn New Technique in Incision Free Bariatric Surgery: Will be Pioneers in This Field in South Asia
New York, NY, December 23, 2011 --(PR.com)-- Drs. PK Reddy, Arun Prasad and Rajkumar Palaniappan, three experienced bariatric surgeons from India’s premier private healthcare group, Apollo Hospitals, recently visited New York to learn cutting edge endoluminal techniques in bariatric surgery. They all attended a one-day animal laboratory session moderated by Dr. Elliot Goodman of Beth Israel Medical Center and the Albert Einstein College of Medicine. They were shown the second-generation OverStitch device made by Apollo Endosurgery, a pioneer in flexible/endoluminal surgery based in Austin, Texas. Apollo Endosurgery was represented in New York at this training session by Ted Stephens, its Director of Marketing. Dr. Goodman and Mr. Stephens gave overviews on the Apollo Endosurgery OverStitch platform to the visiting surgeons, who were able to get invaluable hands-on experience with the new second-generation device.
The next day, the three visiting surgeons observed three live endoluminal cases employing the OverStitch platform at Beth Israel Medical Center. They were hosted by Dr. Goodman and his partner Dr. Burton Surick. Dr. Goodman and Dr. Surick performed two endoluminal pouch reduction procedures as well as an endoluminal closure of a gastro-gastric fistula. All three patients had previously undergone gastric bypass surgery.
Having completed their intensive 2-day introduction in endoluminal surgery, Drs. Reddy, Dr. Prasad and Palaniappan returned to India, keen to put this new knowledge into clinical practice. Dr. Goodman and Mr. Stephens are planning to travel to Chennai to represent Apollo Endosurgery at a bariatric symposium, hosted by Dr. Reddy and the Apollo Hospital Group in Chennai in late January 2012. Dr. Goodman will present a lecture on endoluminal innovations in bariatric surgery, and will then participate in a live surgery case with his Indian colleagues.
After the symposium, Drs. Reddy, Prasad and Palaniappan hope to begin recruiting patients into two clinical trials co-ordinated by Apollo Endosurgery investigating the use of the OverStitch platform in both primary endoluminal bariatric surgery as well as endoluminal revisional bariatric surgery. These trials are the products of a Memorandum of Understanding signed by both Apollo Endosurgery and Apollo Hospitals Group in Chennai in September 2011. This MoU was facilitated by PrimeSource Medtech LLP, a leading medtech consulting company based in Mumbai and New York.
“We believe that flexible surgery represents the most exciting innovation in bariatric and gastrointestinal surgery in years and we look forward to offering these incisionless procedures to our patients to help combat obesity and other conditions,” said Prathap C. Reddy, M.D. Chairman of Apollo Hospitals Group.
J. Lee Putman, Global VP of Sales & Marketing for Apollo Endosurgery, commented that “We are thrilled and honored to enter into this collaboration with Apollo Hospitals Group to bring less invasive flexible surgical devices and techniques to Indian patients.” The facilitator of the training event, Dr. Goodman, added that “This represents a tremendous milestone for the evolution of GI surgery as it progresses from open to laparoscopic and now incision-free access.”
About Apollo Endosurgery®, Inc.:
Apollo Endosurgery®, Inc. is dedicated to revolutionizing patient care through the development of flexible surgery, which is emerging from the convergence of laparoscopic surgery and therapeutic gastroenterology. Flexible surgery minimizes the trauma of surgical access by taking advantage of natural orifices to deliver surgical tools to targeted areas. All of Apollo’s products are compatible with existing flexible endoscope platforms.
About Apollo Hospitals Group:
With over 8,500 beds across 54 hospitals, Apollo Hospitals Group is one of the largest healthcare networks in Asia. The hospitals are multi-specialty tertiary care facilities with centers of excellence across in medical disciplines. Committed to the development of unique centers of excellence and quality healthcare accessible to all, Apollo Hospitals has earned Joint Commission International (JCI) accreditations for seven of its hospitals, the most by any hospital group in the region.
About Primesource Medtech:
PrimeSource MedTech is a young and dynamic healthcare company based both in Mumbai and New York. It aims to bring innovative medical technology in the fields of GI/bariatric surgery and gastroenterology into India at either clinical trial or commercialization phases by leveraging its many connections with the Indian healthcare community, the American and European manufacturing sector and US and Indian venture capital and private equity/banking firms.
###
The next day, the three visiting surgeons observed three live endoluminal cases employing the OverStitch platform at Beth Israel Medical Center. They were hosted by Dr. Goodman and his partner Dr. Burton Surick. Dr. Goodman and Dr. Surick performed two endoluminal pouch reduction procedures as well as an endoluminal closure of a gastro-gastric fistula. All three patients had previously undergone gastric bypass surgery.
Having completed their intensive 2-day introduction in endoluminal surgery, Drs. Reddy, Dr. Prasad and Palaniappan returned to India, keen to put this new knowledge into clinical practice. Dr. Goodman and Mr. Stephens are planning to travel to Chennai to represent Apollo Endosurgery at a bariatric symposium, hosted by Dr. Reddy and the Apollo Hospital Group in Chennai in late January 2012. Dr. Goodman will present a lecture on endoluminal innovations in bariatric surgery, and will then participate in a live surgery case with his Indian colleagues.
After the symposium, Drs. Reddy, Prasad and Palaniappan hope to begin recruiting patients into two clinical trials co-ordinated by Apollo Endosurgery investigating the use of the OverStitch platform in both primary endoluminal bariatric surgery as well as endoluminal revisional bariatric surgery. These trials are the products of a Memorandum of Understanding signed by both Apollo Endosurgery and Apollo Hospitals Group in Chennai in September 2011. This MoU was facilitated by PrimeSource Medtech LLP, a leading medtech consulting company based in Mumbai and New York.
“We believe that flexible surgery represents the most exciting innovation in bariatric and gastrointestinal surgery in years and we look forward to offering these incisionless procedures to our patients to help combat obesity and other conditions,” said Prathap C. Reddy, M.D. Chairman of Apollo Hospitals Group.
J. Lee Putman, Global VP of Sales & Marketing for Apollo Endosurgery, commented that “We are thrilled and honored to enter into this collaboration with Apollo Hospitals Group to bring less invasive flexible surgical devices and techniques to Indian patients.” The facilitator of the training event, Dr. Goodman, added that “This represents a tremendous milestone for the evolution of GI surgery as it progresses from open to laparoscopic and now incision-free access.”
About Apollo Endosurgery®, Inc.:
Apollo Endosurgery®, Inc. is dedicated to revolutionizing patient care through the development of flexible surgery, which is emerging from the convergence of laparoscopic surgery and therapeutic gastroenterology. Flexible surgery minimizes the trauma of surgical access by taking advantage of natural orifices to deliver surgical tools to targeted areas. All of Apollo’s products are compatible with existing flexible endoscope platforms.
About Apollo Hospitals Group:
With over 8,500 beds across 54 hospitals, Apollo Hospitals Group is one of the largest healthcare networks in Asia. The hospitals are multi-specialty tertiary care facilities with centers of excellence across in medical disciplines. Committed to the development of unique centers of excellence and quality healthcare accessible to all, Apollo Hospitals has earned Joint Commission International (JCI) accreditations for seven of its hospitals, the most by any hospital group in the region.
About Primesource Medtech:
PrimeSource MedTech is a young and dynamic healthcare company based both in Mumbai and New York. It aims to bring innovative medical technology in the fields of GI/bariatric surgery and gastroenterology into India at either clinical trial or commercialization phases by leveraging its many connections with the Indian healthcare community, the American and European manufacturing sector and US and Indian venture capital and private equity/banking firms.
###
Contact
Prime Source
Dr Elliot R Goodman
1-718-213-3407
Dr Elliot R Goodman
1-718-213-3407
Contact
Multimedia
The Apollo Overstitch Gen # 2 device
A unique device that mimics the way physicians deploy sutures by hand, the OverStitch system enables full-thickness endoscopic suturing on a flexible platform --- delivering a surgical standard of care through the flexible endoscope.
Categories